Literature DB >> 29780166

NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.

Sheng Tan1, Hua Li2, Weijie Zhang1, Yunying Shao1, Yuan Liu1, Haiyang Guan1, Jun Wu2, Yani Kang2, Junsong Zhao1, Qing Yu1, Yunzhao Gu2, Keshuo Ding3, Min Zhang1, Wenchang Qian1, Yong Zhu1, Huayong Cai1, Changyu Chen4, Peter E Lobie5, Xiaodong Zhao6, Jielin Sun7, Tao Zhu8.   

Abstract

Alternative polyadenylation (APA) is an important post-transcriptional regulatory mechanism and involved in many diseases, including cancer. CFIm25, a subunit of the cleavage factor I encoded by NUDT21, is required for 3'RNA cleavage and polyadenylation. Although it has been recently reported to be involved in glioblastoma tumor suppression, its roles and the underlying functional mechanism remain unclear in other types of cancer. In this study, we characterized NUDT21 in hepatocellular carcinoma (HCC). Reduced expression of NUDT21 was observed in HCC tissue compared to adjacent non-tumorous compartment. HCC patients with lower NUDT21 expression have shorter overall and disease-free survival times than those with higher NUDT21 expression after surgery. Knockdown of NUDT21 promotes HCC cell proliferation, metastasis, and tumorigenesis, whereas forced expression of NUDT21 exhibits the opposite effects. We then performed global APA site profiling analysis in HCC cells and identified considerable number of genes with shortened 3'UTRs upon the modulation of NUDT21 expression. In particular, we further characterized the NUDT21-regulated genes PSMB2 and CXXC5. We found NUDT21 knockdown increases usage of the proximal polyadenylation site in the PSMB2 and CXXC5 3' UTRs, resulting in marked increase in the expression of PSMB2 and CXXC5. Moreover, knockdown of PSMB2 or CXXC5 suppresses HCC cell proliferation and invasion. Taken together, our study demonstrated that NUDT21 inhibits HCC proliferation, metastasis and tumorigenesis, at least in part, by suppressing PSMB2 and CXXC5, and thereby provided a new insight into understanding the connection of HCC suppression and APA machinery.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29780166     DOI: 10.1038/s41388-018-0280-6

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  Molecular architecture of the human pre-mRNA 3' processing complex.

Authors:  Yongsheng Shi; Dafne Campigli Di Giammartino; Derek Taylor; Ali Sarkeshik; William J Rice; John R Yates; Joachim Frank; James L Manley
Journal:  Mol Cell       Date:  2009-02-13       Impact factor: 17.970

2.  Structural basis of UGUA recognition by the Nudix protein CFI(m)25 and implications for a regulatory role in mRNA 3' processing.

Authors:  Qin Yang; Gregory M Gilmartin; Sylvie Doublié
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

3.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

4.  Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing.

Authors:  Yonggui Fu; Yu Sun; Yuxin Li; Jie Li; Xingqiang Rao; Chong Chen; Anlong Xu
Journal:  Genome Res       Date:  2011-04-07       Impact factor: 9.043

Review 5.  Mechanisms and consequences of alternative polyadenylation.

Authors:  Dafne Campigli Di Giammartino; Kensei Nishida; James L Manley
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

6.  RINF (CXXC5) is overexpressed in solid tumors and is an unfavorable prognostic factor in breast cancer.

Authors:  S Knappskog; L M Myklebust; C Busch; T Aloysius; J E Varhaug; P E Lønning; J R Lillehaug; F Pendino
Journal:  Ann Oncol       Date:  2011-02-16       Impact factor: 32.976

Review 7.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

8.  Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation.

Authors:  Wayne O Miles; Antonio Lembo; Angela Volorio; Elena Brachtel; Bin Tian; Dennis Sgroi; Paolo Provero; Nicholas Dyson
Journal:  Cancer Res       Date:  2016-10-10       Impact factor: 12.701

Review 9.  Alternative Polyadenylation: Another Foe in Cancer.

Authors:  Ayse Elif Erson-Bensan; Tolga Can
Journal:  Mol Cancer Res       Date:  2016-04-13       Impact factor: 5.852

10.  NUDT21-spanning CNVs lead to neuropsychiatric disease and altered MeCP2 abundance via alternative polyadenylation.

Authors:  Vincenzo A Gennarino; Callison E Alcott; Chun-An Chen; Arindam Chaudhury; Madelyn A Gillentine; Jill A Rosenfeld; Sumit Parikh; James W Wheless; Elizabeth R Roeder; Dafne D G Horovitz; Erin K Roney; Janice L Smith; Sau W Cheung; Wei Li; Joel R Neilson; Christian P Schaaf; Huda Y Zoghbi
Journal:  Elife       Date:  2015-08-27       Impact factor: 8.140

View more
  33 in total

1.  Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.

Authors:  Junsuk Ko; Tingting Mills; Jingjing Huang; Ning-Yuan Chen; Tinne C J Mertens; Scott D Collum; Garam Lee; Yu Xiang; Leng Han; Yang Zhou; Chun Geun Lee; Jack A Elias; Soma S K Jyothula; Keshava Rajagopal; Harry Karmouty-Quintana; Michael R Blackburn
Journal:  J Biol Chem       Date:  2019-09-05       Impact factor: 5.157

Review 2.  CFIm25 and alternative polyadenylation: Conflicting roles in cancer.

Authors:  Mohammad Hassan Jafari Najaf Abadi; Rana Shafabakhsh; Zatollah Asemi; Hamid Reza Mirzaei; Roxana Sahebnasagh; Hamed Mirzaei; Michael R Hamblin
Journal:  Cancer Lett       Date:  2019-06-07       Impact factor: 8.679

3.  CFIm-mediated alternative polyadenylation remodels cellular signaling and miRNA biogenesis.

Authors:  Souvik Ghosh; Meric Ataman; Maciej Bak; Anastasiya Börsch; Alexander Schmidt; Katarzyna Buczak; Georges Martin; Beatrice Dimitriades; Christina J Herrmann; Alexander Kanitz; Mihaela Zavolan
Journal:  Nucleic Acids Res       Date:  2022-04-08       Impact factor: 16.971

4.  Shortening of the KHDRBS1 3'UTR by alternative cleavage and polyadenylation alters miRNA-mediated regulation and promotes gastric cancer progression.

Authors:  Xin Yu; Weibiao Kang; Jiajia Zhang; Changyu Chen; Yi Liu
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

5.  PSMB2 knockdown suppressed proteasome activity and cell proliferation, promoted apoptosis, and blocked NRF1 activation in gastric cancer cells.

Authors:  Zimeng Liu; Changda Yu; Zhibing Chen; Chuanwen Zhao; Lin Ye; Chen Li
Journal:  Cytotechnology       Date:  2022-06-27       Impact factor: 2.040

Review 6.  Context-specific regulation and function of mRNA alternative polyadenylation.

Authors:  Sibylle Mitschka; Christine Mayr
Journal:  Nat Rev Mol Cell Biol       Date:  2022-07-07       Impact factor: 113.915

7.  Alu RNA and their roles in human disease states.

Authors:  Daniel Gussakovsky; Sean A McKenna
Journal:  RNA Biol       Date:  2021-10-21       Impact factor: 4.766

Review 8.  Emerging Roles of RNA 3'-end Cleavage and Polyadenylation in Pathogenesis, Diagnosis and Therapy of Human Disorders.

Authors:  Jamie Nourse; Stefano Spada; Sven Danckwardt
Journal:  Biomolecules       Date:  2020-06-17

9.  CFIm25 in Solid Tumors: Current Research Progress.

Authors:  Xiaojie Sun; Ji Li; Xun Sun; Wanqi Liu; Xiangwei Meng
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

10.  NUDT21 Suppresses Breast Cancer Tumorigenesis Through Regulating CPSF6 Expression.

Authors:  Bi-Jun Wang; Da-Chao Liu; Qian-Ying Guo; Xiao-Wen Han; Xiao-Min Bi; Hao Wang; Zheng-Sheng Wu; Wen-Yong Wu
Journal:  Cancer Manag Res       Date:  2020-05-01       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.